What is the role of tacrolimus and pimecrolimus in atopic dermatitis?

MOspace/Manakin Repository

Breadcrumbs Navigation

What is the role of tacrolimus and pimecrolimus in atopic dermatitis?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3381

[+] show full item record


Title: What is the role of tacrolimus and pimecrolimus in atopic dermatitis?
Author: Trammell, Sara; Shakil, Amer; Wilder, Laura
Keywords: eczema
topical immunosuppressant
corticosteroids
Date: 2005-08
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 54(8) 2005: 714-716.
Abstract: When the standard therapies—mild topical corticosteroids and moisturizers—fail in the treatment of atopic dermatitis, patients are left with few proven remedies. The recently introduced topical immunosuppressive treatments—pimecrolimus and tacrolimus—offer an alternative to topical corticosteroids. Tacrolimus 0.1% (Protopic) appears to be both safe and effective in treating eczema in adults and children (strength of recommendation [SOR]: A). In multiple studies, it has been as effective as potent topical corticosteroids and more effective than mild topical corticosteroids (SOR: A). Pimecrolimus (Elidel) is more effective than placebo but less effective than potent topical corticosteroids (SOR: A). At this time, no data compare pimecrolimus with mild corticosteroids.
URI: http://hdl.handle.net/10355/3381

This item appears in the following Collection(s)

[+] show full item record